NCT00002675View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Retinoblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 1995

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Retinoblastoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

mesna

DRUG

vincristine sulfate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002675 - Chemotherapy in Treating Patients With Retinoblastoma | Biotech Hunter | Biotech Hunter